News

FDA Approval Of Tec-Dara: A Powerful Treatment Option For Patients With Relapsed Multiple Myeloma

Mar 9, 2026 in Multiple Myeloma

Diagnosing Muscle-Invasive Bladder Cancer: The Initial Work-Up

Mar 4, 2026 in Bladder Cancer

Man, 56, With Stage 4 Colon Cancer, Finds Hope In hepatic artery infusion (HAI) Treatment

Mar 4, 2026 in Colon Cancer

‘Dramatic Response Rates Without Compromising Quality of Life’: New FDA-Approval Offers Promising Option For Patients With Rare Lung Cancer Subtype

Mar 4, 2026 in Lung Cancer

New Study Shows Potential for Earlier Use of Pluvicto in Advanced Prostate Cancer

Mar 2, 2026 in Prostate Cancer

A Breakthrough For Muscle-Invasive Bladder Cancer: Padcev Plus Keytruda Drug Combo Could Transform Treatment Around Surgery

Mar 2, 2026 in Bladder Cancer

'Potentially Practice-Changing': Targeted Therapy Improves Survival For Men With Subtype Of Advanced Prostate Cancer

Mar 2, 2026 in Prostate Cancer

FDA Approves New All-Oral Treatment Option For CLL: What This Means For Patients 

Feb 23, 2026 in Chronic Lymphocytic Leukemia (CLL)

A Simpler Monthly Option for EGFR-Targeted Treatment—What It Means for You

Feb 20, 2026

Bayer's Dr. Dominik Ruettinger On A Promising New Oral Treatment Option For Patients With HER2+ Lung Cancer

Feb 18, 2026

7 Years After Glioma Diagnosis, Vorasidenib Provides Lasting Control

Feb 18, 2026 in Glioma

The Pill Form Of GLP-1 Weight Loss Drugs Is Surging Among Urban, White Women According to Newly Released Data

Feb 18, 2026